About 1,073 results

ALLMedicine™ Dermatofibrosarcoma Protuberans Center

Research & Reviews  340 results

Retrospective Analysis of a Modern Cohort of Dermatofibrosarcoma Protuberans From 2000 ...
Journal of Cutaneous Medicine and Surgery; Baig IT, Lauck K et. al.

Jan 20th, 2023 - There is limited data on how demographics, tumor characteristics, and treatment methods affect overall survival in patients with dermatofibrosarcoma protuberans (DFSP). To summarize characteristics of patients with DFSP, assess prognostic factors,...

Outcome After Surgical Treatment of Dermatofibrosarcoma Protuberans (DFSP): Does it Req...
Annals of Surgical Oncology; Alshaygy I, Mattei JC et. al.

Jan 20th, 2023 - Dermatofibrosarcoma protuberans (DFSP) is a rare cutaneous tumour of indeterminate malignant potential. The mainstay treatment for DFSP is surgical resection. Given the reported high local recurrence rate, the ideal resection margin for DFSP is un...

Dermatofibrosarcoma protuberans challenges: a case series and review of the literature.
Journal of Medical Case Reports; Sheidaei S, Salehi M et. al.

Jan 19th, 2023 - Dermatofibrosarcoma protuberans (DFSP) is a rare variant of skin sarcoma which is characterized by proliferation of spindle cells in a storiform pattern. Although it is mostly benign in its primary stages, it can cause a high burden of morbidity u...

Review of dermatofibrosarcoma protuberans.
Clinical and Experimental Dermatology; Lim SX, Ramaiya A et. al.

Jan 12th, 2023 - The clinical features, histological subtypes and management of dermatofibrosarcoma protuberans (DFSP) are reviewed in this article. DFSP is an uncommon cutaneous sarcoma first described in 1890. It has a high local recurrence rate, low metastatic ...

Dermatofibrosarcoma Protuberans Recurrence After Wide Local Excision Versus Mohs Microg...
Dermatologic Surgery : Official Publication for American ...

Jan 12th, 2023 - Dermatofibrosarcoma Protuberans Recurrence After Wide Local Excision Versus Mohs Micrographic Surgery: A Systematic Review and Meta-Analysis: Erratum.|2023||

see more →

Guidelines  1 results

Dermatofibrosarcoma protuberans.
Journal of the National Comprehensive Cancer Network : JN... Miller SJ, Alam M et. al.

Mar 7th, 2012 - Dermatofibrosarcoma protuberans.|2012|Miller SJ,Alam M,Andersen JS,Berg D,Bichakjian CK,|diagnosis,therapy,

see more →

Drugs  20 results see all →

Clinicaltrials.gov  8 results

Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger

Aug 5th, 2020 - The purpose of this proposed study is to assess effectiveness of MOHS micrographic surgery as a form of treatment for dermatofibrosarcoma protuberans in patients who are 10 years of age or younger through review of the patients at Mayo Clinic trea...

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

Feb 23rd, 2017 - Condition Diverse malignancies either associated with or thought to be associated with activated tyrosine kinase enzymes including hypereosinophilic syndrome systemic mastocytosis chronic myelomonocytic leukaemia, dermatofibrosarcoma protuberans a...

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

Jan 20th, 2016 - OBJECTIVES: Primary Determine the response rate (complete response and partial response) in patients with metastatic, locally advanced, or locally recurrent non-gastrointestinal stromal tumor sarcomas treated with sunitinib malate. Secondary Deter...

Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans

Feb 28th, 2013 - PRIMARY OBJECTIVES: I. To assess the response rate (confirmed complete and confirmed partial response) in patients with locally advanced or metastatic dermatofibrosarcoma protuberans (DFSP) treated with imatinib. II. To estimate the one-year progr...

Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma

Sep 24th, 2012 - OBJECTIVES: Primary Determine the therapeutic activity of imatinib mesylate in patients with locally advanced or metastatic dermatofibrosarcoma protuberans or giant cell fibroblastoma. Determine the progression-free rate at 14 weeks in patients tr...

see more →

News  48 results

Scar overgrowth
MDedge Family Medicine;

Jan 4th, 2023 - Dermatopathology was consistent with a diagnosis of cutaneous myxoma (CM). There are very few dermoscopic descriptions of CM in the literature, so diagnostic features are not established.

Margin Size for Unique Skin Tumors Treated With Mohs Micrographic Surgery: A Survey of Practice Patterns
Frances M. Walocko, MD, MEng, Christian Carr, MPH et. al.

Oct 6th, 2022 - Mohs micrographic surgery (MMS) is most commonly used for the surgical management of squamous cell carcinomas (SCCs) and basal cell carcinomas (BCCs) in high-risk locations. The ability for 100% margin evaluation with MMS also has shown lower recu.

Hyperpigmented plaque on back
MDedge Family Medicine;

Feb 3rd, 2022 - Based on the thickness and size of this irregular lesion, a punch biopsy was performed and confirmed the diagnosis of dermatofibrosarcoma protuberans (DFSP). DFSPs are usually found on the trunk and proximal extremities; they are most often locate.

Erythematous Indurated Nodule on the Forehead
Karan Pandher, MD, Felipe B. Cerci, MD, MSc et. al.

Jan 10th, 2022 - The Diagnosis: Dermatofibrosarcoma Protuberans Histopathologic examination showed a dermal tumor composed of spindle cells in a storiform arrangement (Figure 1). Immunohistochemistry demonstrated positive CD34 staining of the tumoral cells (Figure.

Dr. Alshaygy on Resection Margin for Dermatofibrosarcoma Protuberans

Oct 6th, 2021 - Ibrahim S. Alshaygy, MD, MSC, a clinical fellow in Orthopedic Oncology at Mount Sinai Hospital, discusses research suggesting a smaller surgical resection margin for dermatofibrosarcoma protuberans (DFSP). DFSP is an uncommon continuous tumor wit...

see more →

Patient Education  12 results see all →